This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Proyecto De Biomedicina Cima, S.l.. Active years: 2012.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2012
Title: Lorea Manterola Careaga: Innovator in Biomedical Research
Introduction
Lorea Manterola Careaga is a prominent inventor based in Pamplona-Navarra, Spain. She has made significant contributions to the field of biomedical research, particularly in the development of peptides that interact with interleukin-10 (IL-10). Her innovative work has the potential to impact the treatment of various clinical conditions.
Latest Patents
Lorea holds a patent for peptides with the capacity to bind with interleukin-10 (IL-10). This invention relates to peptides that can bind to IL-10 and their application in treating clinical conditions or pathological disorders associated with IL-10 expression. This includes conditions characterized by high IL-10 expression, such as infectious diseases, tumors, cancers, and acute damage conditions.
Career Highlights
Lorea is associated with Proyecto De Biomedicina Cima, S.L., where she continues to advance her research and innovations. Her work is recognized for its potential to address significant health challenges through the development of novel therapeutic approaches.
Collaborations
Lorea collaborates with notable colleagues, including Inés Noelia Casares Lagar and Nancy Díaz-Valdés Farray. These partnerships enhance her research efforts and contribute to the advancement of biomedical science.
Conclusion
Lorea Manterola Careaga is a dedicated inventor whose work in peptide research holds promise for improving treatments for various diseases. Her contributions to biomedical innovation are noteworthy and reflect her commitment to advancing healthcare solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile